Insurances.net
insurances.net » Auto Insurance » Stem Cell Therapy For Spinal Cord Injury-aarkstore Enterprise
Auto Insurance Life Insurance Health Insurance Family Insurance Travel Insurance Mortgage Insurance Accident Insurance Buying Insurance Housing Insurance Personal Insurance Medical Insurance Property Insurance Pregnant Insurance Internet Insurance Mobile Insurance Pet Insurance Employee Insurance Dental Insurance Liability Insurance Baby Insurance Children Insurance Boat Insurance Cancer Insurance Insurance Quotes Others
]

Stem Cell Therapy For Spinal Cord Injury-aarkstore Enterprise

Stem Cell Therapy For Spinal Cord Injury-aarkstore Enterprise

Stem Cell Therapy for Spinal Cord Injury report presents 12 R & D stem cell-based product profiles

, 10 company profiles and investors information. This report emphasizes advantages and disadvantages of particular cell therapies for spinal cord injury, characteristics and origin of used cells, mechanism of their action, efficacy and adverse effects, mode of delivery, design of clinical trials and result of completed clinical studies.

When considering stem cell therapy, as the new avenue for the treatment of spinal cord injury, it is important to remember that spinal cord is a very complex structure containing a maze of various cells, neuronal extensions, electrical signals and chemical transmissions, presenting extremely difficult task for its regeneration and functional recovery. In addition, injured spinal cord represents one of the most hostile tissue environments for survival and therapeutic effect of transplanted stem and progenitor cells.

Analysis reveals that in the last two years research related to stem cell therapies for the treatment of spinal cord injury had abruptly and significantly shifted from mesenchymal and mesenchymal-like stem cells towards neural stem cells. However, in the commercial R & D pipeline, undergoing development by various companies, the majority (75%) of stem cells used for the treatment of spinal cord injury are mesenchymal stem cells and mesenchymal-like stem cells, which are undifferentiated in 55% of those products. Autologus stem cells, obtained from patients own tissues are used in 66%, embryonic-derived stem cells in 17% and allogenic stem cells in 17% of all stem cell transplantations for the treatment of spinal cord injury. Half of products are in preclinical stage of development and only one is in Phase II clinical trials. Out of 10 companies involved in research and development of stem cell-based therapies for spinal cord injury eight are from the USA, one is from Asia and one is from Europe. None of the major pharmaceutical or biotechnology companies are involved in development of stem cell products for the treatment of spinal cord injury.

For more information please visit:

http://www.aarkstore.com/reports/Stem-Cell-Therapy-for-Spinal-Cord-Injury-37959.html

PH.NO. 919272852585

by: Aarkstore Enterprise
Tips To Save In Las Vegas Auto Insurance You Will Need These Especially If Youre In Vegas The Linear Packaging Of The Automotive Light Source An Insight Into The Car Shipping Insurance Why Getting Hold Of Cincinnati Auto Insurance A Primary Concern? Quick Alabama Auto Insurance - Are You Satisfied With Your Auto Insurance Policy? Himfr Reports Automobile Market Potential Can Be Expected If You Are Looking For Used Commercial Truck Parts, You Need Not Look Beyond Automotix Grand Theft Auto: Vice City Evaluate for that Playstation two Enjoy the Benefits of a 72 Month Auto Loan Why You Need Car Insurance Quick Arvada Auto Insurance - Are You Satisfied With Your Auto Insurance Policy? The Danger Of Zero Down, Zero Interest Auto Loans Ways To Find The Best Auto Insurance Ratings
Write post print
www.insurances.net guest:  register | login | search IP(18.224.63.87) Hovedstaden / Copenhagen Processed in 0.011857 second(s), 6 queries , Gzip enabled debug code: 12 , 2351, 952,
Stem Cell Therapy For Spinal Cord Injury-aarkstore Enterprise Copenhagen